Presentation is loading. Please wait.

Presentation is loading. Please wait.

“2nd World Congress on Rare Diseases and Orphan Drugs”

Similar presentations


Presentation on theme: "“2nd World Congress on Rare Diseases and Orphan Drugs”"— Presentation transcript:

1 “2nd World Congress on Rare Diseases and Orphan Drugs”
Management of Rare Diseases: An Integrated Approach to Break Down Barriers and Facilitate Patient Access to Healthcare “2nd World Congress on Rare Diseases and Orphan Drugs” Date: 29th and 30th June, 2017

2 “I am Dr. Gayathri Balasubramanian, a part of focus scientific research center, the scientific arm of phamax, which is a healthcare market access company. The views presented here are from secondary desk research and various initiatives undertaken by phamax at a global level.” Disclosure

3 Rare diseases – A snapshot
350 M 80% 50% 35%

4 Now a global issue Developed Countries Developing Countries
More than 6,000 rare diseases Rare disease affects < 1/500,000 More than 7,000 rare diseases Affects ~30 M European Union citizens Neonatal morbidity of < 1/10,000 Rare disease affects < 0.1% of the population ~ 70 M Indians are affected

5 Unaffordability Untreated cases Underdiagnoses Undefined process
Unavailing research Unawareness Unavailing research Undefined process Underdiagnoses Untreated cases Unaffordability Unawareness

6 Stakeholders’ Network
Journey so far Initiatives Plans and Policies Data/Registry Access Programs Cost of Care Centers of Excellence Stakeholders’ Network Comprehensive - Care

7 Recommendations Process Collaboration Awareness Regulations Guidelines
Policy Makers/Regulatory Bodies Healthcare Providers Process Collaboration Awareness Regulations Guidelines Policies Continued education Training Clinical guidelines Centers of excellence Comprehensive care Industry Partners/Researchers Patients/Patient Organization Continued research Drug development Mixed-methods research Awareness Advocacy Pathway establishment

8 Integrated Approach Drivers and Barriers Technology Novel Research
Stakeholders

9 Implementation Engage Develop Build Generate Collaborate Identify
Disseminate Facilitate

10 Lessons learnt from our experience
Tackling hepatitis in Africa – A Case study REACH Problem 01 Objective 02 Epidemiology Awareness Collaboration Health access Research Continued Approach 03 Outcomes 04

11 Global network of ~2,000 stakeholders of health; both international and local experts Network Composition: Physicians: 68% Policy: 23% Patient bodies: 9%

12 Thank you


Download ppt "“2nd World Congress on Rare Diseases and Orphan Drugs”"

Similar presentations


Ads by Google